Trial Profile
A multi-center, multiple dose, open-label, four-cohort, parallel study to assess the pharmacokinetic drug interaction following co-administration of valsartan, hydrochlorothiazide and amlodipine in patients with hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2010
Price :
$35
*
At a glance
- Drugs Valsartan (Primary) ; Amlodipine; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Novartis
- 21 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2007 New trial record.